Kinesiology researchers at the University of Massachusetts Amherst have received funding to compare the effects Kinesiology researchers at the University of Massachusetts Amherst have received funding to compare the effects of tai chi and mindfulness meditation on both the physical balance and psychosocial well-being of people with multiple sclerosis both the physical balance and psychosocial […]Continue Reading ...
A recent study found that nearly 18 percent of patients diagnosed with multiple sclerosis before being referred to two major Los Angeles medical centers for treatment actually had been misdiagnosed with the autoimmune disease. The retrospective study, led by investigator Marwa Kaisey, MD, along with Nancy Sicotte, MD, interim chair of Neurology and director of […]Continue Reading ...
Researchers have shown that analyzing dried urine extracts with GC-MS/MS to assess levels of reproductive hormones in pre-and post-menopausal women provides similar results to radioimmunoassays using serum samples. Kateryna Kon | Shutterstock They also showed that collecting four urine samples throughout the day (the 4-spot method) is a suitable substitute for a 24-hour urine collection. […]Continue Reading ...
THURSDAY, March 28, 2019 — An older but still common multiple sclerosis (MS) treatment has an unexpected perk: It not only quells symptoms, but patients may also live longer. New research revealed that patients taking a beta interferon drug for more than three years were likely to live longer than those who took one for […]Continue Reading ...
FDA Approves Mavenclad (cladribine) Tablets for Multiple Sclerosis March 29, 2019 — The U.S. Food and Drug Administration today approved Mavenclad (cladribine) tablets to treat relapsing forms of multiple sclerosis (MS) in adults, to include relapsing-remitting disease and active secondary progressive disease. Mavenclad is not recommended for MS patients with clinically isolated syndrome. Because of […]Continue Reading ...
The U.S. Food and Drug Administration today approved Mayzent (siponimod) tablets to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. “Multiple sclerosis can have a profound impact on a person’s life,” said Billy Dunn, M.D., director of the Division of Neurology Products […]Continue Reading ...
FRIDAY, March 22, 2019 — Proper treatment can help people with multiple sclerosis (MS) contend with their disease, an expert says. “Patients get a predisposed feeling that their life is doomed. That it’s going to be a complicated life, which isn’t…Continue Reading ...
Seemingly overnight, healthy children develop mysterious, potentially disabling symptoms. When children finally receive a diagnosis, often after weeks of tests and office and hospital visits, the parents may be shocked to learn that they have multiple sclerosis – a potentially disabling autoimmune disease once believed to affect only adults. “For many years, the tagline for […]Continue Reading ...
Parents of a child with pediatric onset multiple sclerosis may need long-term supports from mental health professionals and advocacy organizations to cope with the emotional and financial impact the disease has on their family, according to a new study co-written by Theodore P. Cross, a senior research specialist in social work at the University of […]Continue Reading ...
MONDAY, April 1, 2019 — The U.S. Food and Drug Administration has approved another new multiple sclerosis drug — the second in one week. Mavenclad (cladribine) pills can be used to treat relapsing forms of MS in adults, including relapsing-remitting disease and active secondary progressive disease. The drug is not recommended for MS patients with […]Continue Reading ...
WEDNESDAY, March 27, 2019 — Mayzent (siponimod) pills have been approved by the U.S. Food and Drug Administration for adults with relapsing multiple sclerosis (MS). “Multiple sclerosis can have a profound impact on a person’s life,” said Dr. Billy Dunn, director of the agency’s Division of Neurology Products. MS is an autoimmune disease of the […]Continue Reading ...
The U.S. Food and Drug Administration today approved Mavenclad (cladribine) tablets to treat relapsing forms of multiple sclerosis (MS) in adults, to include relapsing-remitting disease and active secondary progressive disease. Mavenclad is not recommended for MS patients with clinically isolated syndrome. Because of its safety profile, the use of Mavenclad is generally recommended for patients […]Continue Reading ...
FDA Approves Mayzent (siponimod) for Secondary Progressive Multiple Sclerosis Basel, March 27, 2019 – Novartis today announced that the US Food and Drug Administration (FDA) has approved Mayzent (siponimod) for the treatment of adults with relapsing forms of multiple sclerosis, including secondary progressive multiple sclerosis (SPMS) with active disease, relapsing remitting multiple sclerosis (RRMS) and […]Continue Reading ...
A new study carried out in Taiwan and published on the Journal of Food and Drug Analysis has found that the majority of Taiwanese people are deficient in vitamin D, with vegans being most at risk. FotoHelin | Shutterstock The study, which was led by Ming-Yeh Yang and Ching-Yuan Huang of Tzu-Chi University, aimed to […]Continue Reading ...
Mar 6 2019 A new study has shown that drinking hot chocolate daily could help to reduce fatigue and tiredness among people suffering from MS (multiple sclerosis). The results of this new study were published in the latest issue of the Journal of Neurology Neurosurgery and Psychiatry. The team of researchers from Oxford Brookes University […]Continue Reading ...
- Angry dreams explained by brain waves
- Parenteral Antimicrobial Tx at Home Burdens Children’s Caregivers
- Diabetes treatment may keep dementia, Alzheimer’s at bay
- New bandage-like biosensor collects and analyzes sweat
- A comprehensive, centralized database of bovine milk compounds
- Two new epigenetic regulators maintain self-renewal of embryonic stem cells
- New Evidence That Veggies Beat Steak for Heart Health
- Study reveals genes associated with heavy drinking and alcoholism
- Texas A&M AgriLife becomes the newest member of NutriRECS international consortium
- In most states, insurance won’t cover addiction treatments
- Computer-based memory games may be beneficial for individuals with fragile X syndrome
- Timing of food intake influences molecular clock in the liver of mice
- Precise decoding of breast cancer cells paves way for new treatment option
- Scientists use 3D imaging to help model complex processes performed by placenta
- MediciNova Announces Plans to Move Forward with a Phase 3 Trial of MN-166 (ibudilast) in ALS
- Genetic variants that protect against obesity could aid new weight loss medicines
- New technology developed for microscopic imaging in living organisms
- when quitting cigarettes, consider using more nicotine, not less
- Key proteins can block Listeria without triggering the death of host cells
- Researchers create a working model of cerebral tract to study brain function